The global whole exome sequencing (WES) market size was significantly robust in 2020 and is expected to register a steady revenue CAGR during the forecast period. Increasing number of research and development activities in pharmaceutical and biotech sectors, advancements in genomic research, rapid adoption of cutting-edge technologies, and rising awareness regarding whole exome sequencing...